FTRE Logo

Fortrea Holdings Inc. - Common Stock (FTRE) Stock Forecast & Price Prediction

Live FTRE Stock Price & Analysis

Home โ€บ Stocks โ€บ United States | NASDAQ | Healthcare | Biotechnology

$15.56

-0.24 (-1.52%)

12 Month Price Forecast For FTRE

$15.56
Current Price
$1.40B
Market Cap
12 Ratings
Buy 1
Hold 10
Sell 1
Wall St Analyst Ratings

Distance to FTRE Price Forecasts

+74.8%
To High Target of $27.20
+41.4%
To Median Target of $22.00
+9.3%
To Low Target of $17.00

FTRE Price Momentum

-7.1%
1 Week Change
-21.1%
1 Month Change
-50.2%
1 Year Change
-16.6%
Year-to-Date Change
-62.1%
From 52W High of $41.02
+1.8%
From 52W Low of $15.29

๐Ÿค” Considering Fortrea Holdings (FTRE)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 6, 2025 3:27 AM UTC

FTRE Analyst Ratings & Price Targets

Based on our analysis of 12 Wall Street analysts, FTRE has a consensus that is neutral. The median price target is $22.00, with forecasts ranging from $17.00 to $27.20. Currently, there are 1 Buy ratings, 10 Hold ratings, and 1 Sell ratings.

With FTRE currently trading at $15.56, the median price forecast suggests a 41.4% upside. The most optimistic forecast comes from at , projecting a 74.8% upside, while at provides the most conservative target, suggesting a 9.3% upside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

FTRE Analyst Consensus

1
Buy
10
Hold
1
Sell

FTRE Price Target Range

Low
$17.00
Average
$22.00
High
$27.20
Current: $15.56

Latest FTRE Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for FTRE.

Date Firm Analyst Rating Change Price Target
Dec 11, 2024 Citigroup Patrick Donnelly Neutral Downgrade $23.00
Dec 6, 2024 Baird Eric Coldwell Neutral Downgrade $25.00
Nov 25, 2024 Baird Outperform Maintains $0.00
Nov 11, 2024 Barclays Luke Sergott Equal-Weight Maintains $25.00
Nov 11, 2024 TD Cowen Charles Rhyee Hold Maintains $25.00
Nov 11, 2024 Baird Eric Coldwell Outperform Maintains $30.00
Nov 8, 2024 William Blair Max Smock Market Perform Reiterates $0.00
Oct 15, 2024 Barclays Luke Sergott Equal-Weight Maintains $20.00
Oct 8, 2024 Evercore ISI Group Elizabeth Anderson In-Line Maintains $20.00
Oct 8, 2024 Goldman Sachs Matthew Sykes Neutral Maintains $23.00
Sep 25, 2024 Jefferies David Windley Hold Downgrade $21.00
Sep 11, 2024 William Blair Max Smock Market Perform Reiterates $0.00
Aug 20, 2024 Deutsche Bank Justin Bowers Hold Maintains $23.00
Aug 13, 2024 Baird Eric Coldwell Outperform Maintains $28.00
Aug 13, 2024 Citigroup Patrick Donnelly Buy Maintains $30.00
Aug 13, 2024 Evercore ISI Group Elizabeth Anderson In-Line Maintains $22.00
Aug 13, 2024 B of A Securities Derik De Bruin Underperform Maintains $21.00
Aug 13, 2024 TD Cowen Charles Rhyee Hold Maintains $23.00
Aug 13, 2024 Barclays Luke Sergott Equal-Weight Maintains $21.00
Aug 12, 2024 William Blair Max Smock Market Perform Reiterates $0.00

Stocks Similar to Fortrea Holdings Inc. - Common Stock

The following stocks are similar to Fortrea Holdings based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Fortrea Holdings Inc. - Common Stock (FTRE) Financial Data

Fortrea Holdings Inc. - Common Stock has a market capitalization of $1.40B with a P/E ratio of 522.3x. The company generates $2.98B in trailing twelve-month revenue with a -10.1% profit margin.

Revenue growth is -5.5% quarter-over-quarter, while maintaining an operating margin of -1.4% and return on equity of -13.6%.

Valuation Metrics

Market Cap $1.40B
Enterprise Value $2.50B
P/E Ratio 522.3x
PEG Ratio 11.9x
Price/Sales 0.5x

Growth & Margins

Revenue Growth (YoY) -5.5%
Gross Margin +22.0%
Operating Margin -1.4%
Net Margin -10.1%
EPS Growth N/A

Financial Health

Cash/Price Ratio +7.5%
Current Ratio 1.2x
Debt/Equity 79.7x
ROE -13.6%
ROA -1.0%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Fortrea Holdings Inc. - Common Stock logo

Fortrea Holdings Inc. - Common Stock (FTRE) Company Overview

About Fortrea Holdings Inc. - Common Stock

What They Do

Provides biopharmaceutical and medical device development services.

Business Model

The company operates as a contract research organization (CRO), generating revenue by offering a range of clinical and enabling services to pharmaceutical, biotechnology, and medical device companies. Its business model includes various delivery structures, such as full service, functional service provider, and hybrid models, which cater to different client needs throughout the clinical trial process.

Additional Information

Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina. It specializes in managing clinical trials from phase I to IV and provides consulting services, leveraging technology to enhance trial efficiency and patient access.

Company Information

Sector

Healthcare

Industry

Biotechnology

Employees

15,500

CEO

Mr. Thomas H. Pike

Country

United States

IPO Year

2023

Fortrea Holdings Inc. - Common Stock (FTRE) Latest News & Analysis

FTRE stock latest news image
Quick Summary

Fortrea (Nasdaq: FTRE) will release its Q4 and full-year 2024 financial results on March 3, 2025, before the market opens, followed by a conference call at 9:00 am ET.

Why It Matters

Fortrea's upcoming financial results announcement and conference call may influence stock performance, investor sentiment, and expectations for future growth or challenges.

Source: GlobeNewsWire
Market Sentiment: Neutral
FTRE stock latest news image
Quick Summary

Pomerantz LLP is investigating claims for Fortrea Holdings Inc. (NASDAQ:FTRE) investors. Interested parties should contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980.

Why It Matters

The investigation into Fortrea Holdings may indicate potential legal issues or financial irregularities, which could impact stock performance and investor sentiment.

Source: Accesswire
Market Sentiment: Neutral
FTRE stock latest news image
Quick Summary

Fortrea, a Labcorp spin-off, shows recovery potential with improved bookings, a 1.23x book-to-bill ratio, and a target price of $45 within a year, despite a 46% drop in 2024.

Why It Matters

Fortrea's recovery signals potential for stock price appreciation due to improved bookings, activist interest, and favorable market conditions, with a target of $45 within a year.

Source: Seeking Alpha
Market Sentiment: Positive
FTRE stock latest news image
Quick Summary

Fortrea (Nasdaq: FTRE) will present at the Citi Global Healthcare Conference on December 4, 2024, at 1:45 pm ET, featuring CEO Tom Pike and CFO Jill McConnell.

Why It Matters

CEO and CFO presentations at major conferences can influence investor sentiment, provide insights into company strategy, and affect stock performance, particularly in the healthcare sector.

Source: GlobeNewsWire
Market Sentiment: Neutral
FTRE stock latest news image
Quick Summary

Fortrea (Nasdaq: FTRE) will present at the Evercore HealthCONx Conference on December 5, 2024, at 10:00 am ET, featuring CEO Tom Pike and CFO Jill McConnell.

Why It Matters

CEO and CFO presentations at a major conference can influence investor sentiment, potentially impacting stock price and market perception of Fortrea's growth and strategy.

Source: GlobeNewsWire
Market Sentiment: Neutral
FTRE stock latest news image
Quick Summary

Fortrea Holdings, Inc. will hold its Q3 2024 earnings conference call on November 8, 2024, at 8:00 AM ET, featuring key company executives and analysts from major financial institutions.

Why It Matters

Fortrea's Q3 earnings call provides insights into financial performance, growth strategies, and market conditions, which can influence stock valuations and investment decisions.

Source: Seeking Alpha
Market Sentiment: Neutral

Frequently Asked Questions About FTRE Stock

What is Fortrea Holdings Inc. - Common Stock's (FTRE) stock forecast for 2025?

Based on our analysis of 12 Wall Street analysts, Fortrea Holdings Inc. - Common Stock (FTRE) has a median price target of $22.00. The highest price target is $27.20 and the lowest is $17.00.

Is FTRE stock a good investment in 2025?

According to current analyst ratings, FTRE has 1 Buy ratings, 10 Hold ratings, and 1 Sell ratings. The stock is currently trading at $15.56. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for FTRE stock?

Wall Street analysts predict FTRE stock could reach $22.00 in the next 12 months. This represents a 41.4% increase from the current price of $15.56. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Fortrea Holdings Inc. - Common Stock's business model?

The company operates as a contract research organization (CRO), generating revenue by offering a range of clinical and enabling services to pharmaceutical, biotechnology, and medical device companies. Its business model includes various delivery structures, such as full service, functional service provider, and hybrid models, which cater to different client needs throughout the clinical trial process.

What is the highest forecasted price for FTRE Fortrea Holdings Inc. - Common Stock?

The highest price target for FTRE is $27.20 from at , which represents a 74.8% increase from the current price of $15.56.

What is the lowest forecasted price for FTRE Fortrea Holdings Inc. - Common Stock?

The lowest price target for FTRE is $17.00 from at , which represents a 9.3% increase from the current price of $15.56.

What is the overall FTRE consensus from analysts for Fortrea Holdings Inc. - Common Stock?

The overall analyst consensus for FTRE is neutral. Out of 12 Wall Street analysts, 1 rate it as Buy, 10 as Hold, and 1 as Sell, with a median price target of $22.00.

How accurate are FTRE stock price projections?

Stock price projections, including those for Fortrea Holdings Inc. - Common Stock, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.